Orticumab Biosimilar – Anti-oxLDL mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameOrticumab Biosimilar - Anti-oxLDL mAb - Research Grade
SourceCAS 1314241-10-5
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsOrticumab,BI-204,MLDL-1278A,R-7418,oxLDL,anti-oxLDL
ReferencePX-TA1299
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-lambda
ClonalityMonoclonal Antibody

Description of Orticumab Biosimilar - Anti-oxLDL mAb - Research Grade

General information on Anti-oxLDL[Homo sapiens] (Orticumab) Monoclonal Antibody

Orticumab is investigated for the treatment of Psoriasis and Cardiometabolic Risk Factors.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Orticumab Biosimilar – Anti-oxLDL mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human OLR1 recombinant protein
Antigen

Human OLR1 recombinant protein

PX-P6045 385€
Stable Isotope Labelled Orticumab Biosimilar – Anti-oxLDL mAb – Research Grade
SIL

Stable Isotope Labelled Orticumab Biosimilar – Anti-oxLDL mAb – Research Grade

PX-TA1299-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products